Physician samples to manufacturers assessable under Rule 4 with Rule 11, not Rule 8 at 110% production cost CESTAT Bangalore held that physician samples cleared to principal manufacturers are assessable under Rule 4 read with Rule 11 of Central Excise Valuation ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Physician samples to manufacturers assessable under Rule 4 with Rule 11, not Rule 8 at 110% production cost
CESTAT Bangalore held that physician samples cleared to principal manufacturers are assessable under Rule 4 read with Rule 11 of Central Excise Valuation Rules, 2000, not Rule 8 at 110% of production cost. Samples for free distribution should be valued at retail sale price of similar goods. Extended period of limitation was deemed unwarranted as the issue involved legal interpretation and appellant had disclosed assessable value in ER1 returns. Penalty imposition was unjustified. Matter remanded to adjudicating authority for duty redetermination following normal limitation period and natural justice principles.
Issues Involved: 1. Method of determination of value of goods. 2. Invoking extended period of limitation. 3. Imposition of penalty.
Summary:
1. Method of Determination of Value of Goods: The primary issue was whether the assessable value of physician samples should be determined under Rule 4 read with Rule 11 or Rule 8 read with Rule 11 of the Central Excise Valuation (Determination of Price of Excisable Goods) Rules, 2000. The adjudicating authority and Commissioner (Appeals) upheld the assessment under Rule 4 read with Rule 11, rejecting the appellant's contention for valuation under Rule 8. The Tribunal cited precedents, including the Supreme Court's decision in Medley Pharmaceuticals, which upheld that physician samples should be valued on a pro-rata basis. The Tribunal concluded that physician samples cleared to the principal manufacturer are assessable under Rule 4 read with Rule 11, not under Rule 8.
2. Invoking Extended Period of Limitation: The appellant argued against the invocation of the extended period of limitation, asserting that duty was paid based on the prevailing law and no facts were suppressed or misdeclared. The Tribunal agreed, noting that the issue related to the interpretation of valuation rules and the appellant had disclosed the assessable value in ER1 returns periodically, making the invocation of the extended period unwarranted.
3. Imposition of Penalty: The Tribunal found no merit in imposing a penalty under Rule 25 of the Central Excise Rules, 2002, as the issue pertained to the interpretation of valuation rules. Consequently, the penalty imposed by the lower authorities was set aside.
Conclusion: The Tribunal modified the impugned order by setting aside the demand for the extended period and the penalty. It remanded the matter to the adjudicating authority for redetermination of duty and interest for the normal period, following the principles of law laid down and observing the principles of natural justice. The appeal was disposed of accordingly.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.